SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-194484
Filing Date
2019-07-16
Accepted
2019-07-16 10:29:33
Documents
10
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d771785d6k.htm 6-K 17462
2 EX-99.1 d771785dex991.htm EX-99.1 10775
3 EX-99.2 d771785dex992.htm EX-99.2 32715
4 EX-99.3 d771785dex993.htm EX-99.3 22525
5 EX-99.4 d771785dex994.htm EX-99.4 9504
6 EX-99.5 d771785dex995.htm EX-99.5 37198
7 EX-99.6 d771785dex996.htm EX-99.6 27963
8 GRAPHIC g771785991.jpg GRAPHIC 5573
9 GRAPHIC g771785g0716171528105.jpg GRAPHIC 2535
10 GRAPHIC g771785gra01.jpg GRAPHIC 9334
  Complete submission text file 0001193125-19-194484.txt   183631
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 19956384
SIC: 2834 Pharmaceutical Preparations